Early Trough Levels and Antibodies Predict Safety and Success of Restarting Infliximab After Long Drug Holiday

被引：0
|
作者：
Baen, Filip J.
Drobne, David
Ballet, Vera
Cleynen, Isabelle
Compemolle, Griet
Riugeens, Paul J.
Van Assche, Gen A.
Gils, Ann
Venneire, Severine
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 46 条
  • [1] Trough Levels and Antidrug Antibodies Predict Safety and Success of Restarting Infliximab After a Long Drug Holiday
    Baert, Filip J.
    Drobne, David
    Ballet, Vera
    Gils, Ann
    Casteele, Niels Vande
    Hauenstein, Scott
    Singh, Sharat
    Lockton, Steven
    Rutgeerts, Paul J.
    Vermeire, Severine
    GASTROENTEROLOGY, 2013, 144 (05) : S91 - S92
  • [2] Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy
    Baert, Filip
    Drobne, David
    Gils, Ann
    Vande Casteele, Niels
    Hauenstein, Scott
    Singh, Sharat
    Lockton, Steve
    Rutgeerts, Paul
    Vermeire, Severine
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (09) : 1474 - U352
  • [3] USING THERAPEUTIC DRUG MONITORING TO PREDICT SUCCESS OF RESTARTING INFLIXIMAB THERAPY AFTER A DRUG HOLIDAY IN INFLAMMATORY BOWEL DISEASE
    Normatov, Inessa
    Wang, Jingzhou D.
    Gulotta, George E.
    Patel, Shivani
    Rubin, David T.
    GASTROENTEROLOGY, 2019, 156 (06) : S876 - S876
  • [4] Infliximab trough levels and anti-drug antibodies after induction predict long-term clinical remission in infliximab-treated patients with inflammatory bowel disease
    Bodini, G.
    Del Nero, L.
    Giannini, E. G.
    Tolone, S.
    De Bortoli, N.
    Anjali, J.
    Baldissarro, I.
    Savarino, V.
    Savarino, E.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S408 - S409
  • [5] INFLIXIMAB TROUGH LEVELS AND ANTI-DRUG ANTIBODIES AFTER INDUCTION AS PREDICTIVE FACTORS OF LONG TERM CLINICAL REMISSION
    Bodini, G.
    Del Nero, L.
    Giannini, E.
    De Maria, C.
    Baldissarro, I
    Savarino, V
    Savarino, E.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E163 - E163
  • [6] Success and safety of high infliximab trough levels in inflammatory bowel disease
    Drobne, David
    Kurent, Tina
    Golob, Sasa
    Svegl, Polona
    Rajar, Polona
    Terzic, Sara
    Kozelj, Matic
    Novak, Gregor
    Smrekar, Natasa
    Plut, Samo
    Sever, Nejc
    Strnisa, Luka
    Hanzel, Jurij
    Brecelj, Jernej
    Urlep, Darja
    Osredkar, Josko
    Homan, Matjaz
    Orel, Rok
    Stabuc, Borut
    Ferkolj, Ivan
    Smid, Alojz
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (08) : 940 - 946
  • [7] Infliximab trough levels and persistent vs transient antibodies measured early after induction predict long-term clinical remission in patients with inflammatory bowel disease
    Bodini, Giorgia
    Giannini, Edoardo G.
    Savarino, Vincenzo
    Del Nero, Lorenzo
    Lo Pumo, Sara
    Brunacci, Matteo
    De Bortoli, Nicola
    Jain, Anjali
    Tolone, Salvatore
    Savarino, Edoardo
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (05) : 452 - 456
  • [8] Comparison of Early Measurement of Infliximab and Antibodies-to-Infliximab Serum Levels With Standard Trough Analysis
    Eser, Alexander
    Primas, Christian
    Hauenstein, Scott
    Lockton, Steven
    Singh, Sharat
    Reinisch, Walter
    GASTROENTEROLOGY, 2013, 144 (05) : S779 - S779
  • [9] Early infliximab trough levels in paediatric IBD patients predict sustained remission
    Bevers, Nanja
    Aliu, Arta
    Wong, Dennis R.
    Winkens, Bjorn
    Vreugdenhil, Anita
    Pierik, Marieke J.
    Derijks, Luc J. J.
    van Rheenen, Patrick F.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [10] Early infliximab trough levels in paediatric IBD patients predict sustained remission
    Bevers, N.
    Aliu, A.
    Wong, D.
    Derijks, L.
    Winkens, B.
    Vreugdenhil, A.
    Pierik, M.
    Van Rheenen, P.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 581 - 582
12345